-
Denosumab, sold
under the
brand name
Prolia among others, is a
human monoclonal antibody used for the
treatment of osteoporosis, treatment-induced bone...
-
imperfecta to
reduce the risk of
broken bones.
Combined teriparatide and
denosumab increased BMD more than
either agent alone and more than has been reported...
- some were
given either 120 mg of
denosumab or 4 mg of
zoledronic acid.
Patients who were
given 120 mg of
denosumab (in
comparison to
those who were given...
- (INN)
denipride (INN)
denopamine (INN)
denosumab (INN)
denosumab-bbdz
denosumab-bmwo
denosumab-bnht
denosumab-dssb
denotivir (INN)
denpidazone (INN) denufosol...
-
disparities exist. She has also
appeared in
commercials for Prolia, a
brand of
denosumab used in the
treatment of osteoporosis.
Danner was
married to producer...
-
incident occurring in 2003.
Osteonecrotic complications ****ociated with
denosumab,
another antiresorptive drug from a
different drug category, were soon...
- rhabdomyolysis,
tumor lysis syndrome, and
medications such as
bisphosphonates or
denosumab.
Diagnosis should generally be
confirmed by
determining the corrected...
- 60-90% of
patients who were
treated for
hypercalcemia of malignancy.
Denosumab is a bone anti-resorptive
agent that can be used to
treat hypercalcemia...
-
relating to the US Food and Drug
Administration (FDA)-approved
Sandoz denosumab biosimilars. In
November 2024,
Sandoz inaugurated the new headquarters...
- medicamentosa.
Denosumab inhibits osteoclast recycling,
which results in the ac****ulation of pre-osteoclasts and osteomorphs. When
denosumab therapy is discontinued...
